These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31365936)

  • 1. High Fetal Fraction on First Trimester Cell-Free DNA Aneuploidy Screening and Adverse Pregnancy Outcomes.
    Shook LL; Clapp MA; Roberts PS; Bernstein SN; Goldfarb IT
    Am J Perinatol; 2020 Jan; 37(1):8-13. PubMed ID: 31365936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Fetal Fraction and Birth Weight in Women with Negative First-Trimester Cell-Free DNA Screening.
    Clapp MA; Berry M; Shook LL; Roberts PS; Goldfarb IT; Bernstein SN
    Am J Perinatol; 2020 Jan; 37(1):86-91. PubMed ID: 31739367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-free DNA fetal fraction and preterm birth.
    Dugoff L; Barberio A; Whittaker PG; Schwartz N; Sehdev H; Bastek JA
    Am J Obstet Gynecol; 2016 Aug; 215(2):231.e1-7. PubMed ID: 26875947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between low fetal fraction of cell free DNA at the early second-trimester and adverse pregnancy outcomes.
    Yuan X; Zhou L; Zhang B; Wang H; Yu B; Xu J
    Pregnancy Hypertens; 2020 Oct; 22():101-108. PubMed ID: 32777709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obstetrical, perinatal, and genetic outcomes associated with nonreportable prenatal cell-free DNA screening results.
    Norton ME; MacPherson C; Demko Z; Egbert M; Malone F; Wapner RJ; Roman AS; Khalil A; Faro R; Madankumar R; Strong N; Haeri S; Silver R; Vohra N; Hyett J; Martin K; Rabinowitz M; Jacobsson B; Dar P
    Am J Obstet Gynecol; 2023 Sep; 229(3):300.e1-300.e9. PubMed ID: 36965866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and no call results: optimal timing of cell-free DNA testing and redraw.
    Hopkins MK; Koelper N; Caldwell S; Dyr B; Dugoff L
    Am J Obstet Gynecol; 2021 Oct; 225(4):417.e1-417.e10. PubMed ID: 33839096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Fetal Fraction of Cell-Free DNA and Hypertensive Disorders of Pregnancy.
    Bender WR; Koelper NC; Sammel MD; Dugoff L
    Am J Perinatol; 2019 Feb; 36(3):311-316. PubMed ID: 30081397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower fetal fraction in clinical cell-free DNA screening results is associated with increased risk of hypertensive disorders of pregnancy.
    Madala D; Maktabi MA; Sabbagh R; Erfani H; Moon A; Van den Veyver IB
    Prenat Diagn; 2022 Sep; 42(10):1253-1261. PubMed ID: 35943975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell free DNA screening for fetal aneuploidy in Ireland: An observational study of outcomes following insufficient fetal fraction.
    Creswell L; Doddy F; Manning C; Nazir SF; Lindow SW; Lynch C; O'Gorman N
    Eur J Obstet Gynecol Reprod Biol; 2023 Nov; 290():143-149. PubMed ID: 37797414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between cell-free DNA fetal fraction and gestational diabetes.
    Hopkins MK; Koelper N; Bender W; Durnwald C; Sammel M; Dugoff L
    Prenat Diagn; 2020 May; 40(6):724-727. PubMed ID: 32091624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequencing shorter cfDNA fragments improves the fetal DNA fraction in noninvasive prenatal testing.
    Qiao L; Yu B; Liang Y; Zhang C; Wu X; Xue Y; Shen C; He Q; Lu J; Xiang J; Li H; Zheng Q; Wang T
    Am J Obstet Gynecol; 2019 Oct; 221(4):345.e1-345.e11. PubMed ID: 31125545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fetal fraction enrichment method reduces false negatives and increases test success rate of fetal chromosome aneuploidy detection in early pregnancy loss.
    Qiao L; Zhang B; Wu X; Zhang C; Xue Y; Tang H; Tang H; Shi J; Liang Y; Yu B; Wang T
    J Transl Med; 2022 Aug; 20(1):345. PubMed ID: 35918754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated Short Fetal Femur Length in the Second Trimester and the Association with Adverse Perinatal Outcome: Experiences from a Tertiary Referral Center.
    Mailath-Pokorny M; Polterauer S; Worda K; Springer S; Bettelheim D
    PLoS One; 2015; 10(6):e0128820. PubMed ID: 26046665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-stage approach for prediction of small-for-gestational-age neonate and adverse perinatal outcome by routine ultrasound examination at 35-37 weeks' gestation.
    Akolekar R; Panaitescu AM; Ciobanu A; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):484-491. PubMed ID: 31271475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-trimester risk assessment based on ultrasound and cell-free DNA vs combined screening: a randomized controlled trial.
    Kagan KO; Sroka F; Sonek J; Abele H; Lüthgens K; Schmid M; Wagner P; Brucker S; Wallwiener D; Hoopmann M
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):437-444. PubMed ID: 28925570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-free DNA fetal fraction in twin gestations in single-nucleotide polymorphism-based noninvasive prenatal screening.
    Hedriana H; Martin K; Saltzman D; Billings P; Demko Z; Benn P
    Prenat Diagn; 2020 Jan; 40(2):179-184. PubMed ID: 31711265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
    Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Not all low fetal fraction cell-free DNA screening failures are at increased risk for aneuploidy.
    Caldwell S; Almasri E; Schmidt L; Xu C; Dyr B; Wardrop J; Cacheris P
    Prenat Diagn; 2021 Oct; 41(11):1372-1379. PubMed ID: 33682142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Term small-for-gestational-age infants from low-risk women are at significantly greater risk of adverse neonatal outcomes.
    Madden JV; Flatley CJ; Kumar S
    Am J Obstet Gynecol; 2018 May; 218(5):525.e1-525.e9. PubMed ID: 29462628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low fetal fraction of cell-free DNA predicts placental dysfunction and hypertensive disease in pregnancy.
    Gerson KD; Truong S; Haviland MJ; O'Brien BM; Hacker MR; Spiel MH
    Pregnancy Hypertens; 2019 Apr; 16():148-153. PubMed ID: 31056151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.